In breast cancer, KDM2A can promote DNA methylation by inhibiting the expression of tet-eleven translocation 2 (TET2), thereby suppressing the expression of epithelial cell adhesion molecule (EpCAM) and E-Cadherin, further enhancing the tumor invasion capacity of breast cancer [21, 22]. This evidence concerns the gene EPCAM and neoplasm.